![]()
|
|
||||||||
The role of protein kinase C (PKC) in the regulation of the
Volume 270,
Number 18,
Issue of May 5, pp. 10952-10959, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
-Adrenergic
Receptor in 3T3-F442A Adipocytes
![]()
-adrenergic receptor (![]()
-AR) gene was
examined in murine 3T3-F442A adipocytes, which express this receptor
subtype at a high level. We also investigated the involvement of this
kinase in the modulation of ![]()
-AR gene expression by
insulin. Long term exposure of 3T3-F442A adipocytes to phorbol
12-myristate 13-acetate (PMA) decreased ![]()
-AR mRNA
content in a time- and concentration-dependent manner, with maximal
changes observed at 6 h (6.5-fold decrease) and at 100 nM PMA.
This inhibition was selective for ![]()
-AR transcripts,
since ![]()
- and ![]()
-AR mRNA content remained
unchanged. Also, (-)-[I]cyanopindolol
saturation and competition binding experiments on adipocyte membranes
indicated that PMA induced an
2-fold decrease in
![]()
-AR expression, while that of the two other subtypes
was not affected. This correlated with a lower efficacy of
![]()
-AR agonists to stimulate adenylyl cyclase.
Conversely, long term exposure to PMA did not alter adenylyl cyclase
activity in response to guanosine 5`- O-(3-thiotriphosphate) or
forskolin. The inactive phorbol ester 4
-phorbol 12,13-didecanoate
did not repress ![]()
-AR mRNA levels. Inhibition of
![]()
-AR mRNA by PMA was suppressed by the PKC-selective
inhibitor bisindolylmaleimide, and was not observed in PKC-depleted
cells, indicating that PKC was involved in this response. mRNA turnover
experiments showed that the half-life of ![]()
-AR
transcripts was not affected by long term PMA exposure. When 3T3-F442A
adipocytes were pretreated with PMA for 24 h to down-regulate PKC, or
with bisindolylmaleimide, the insulin-induced inhibition of
![]()
-AR mRNA levels was reduced by 44-67%. These
findings demonstrate that sustained PKC activation exerts a specific
control of ![]()
-AR gene expression and is involved, at
least in part, in the modulation by insulin of this adrenergic receptor
subtype.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. D. Fullerton, L. Wagner, Z. Yuan, and M. Bakovic Impaired trafficking of choline transporter-like protein-1 at plasma membrane and inhibition of choline transport in THP-1 monocyte-derived macrophages Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1230 - C1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-K. Yeh, T. K. Hymer, A. L. Sousa, B.-X. Zhang, M. D. Lifschitz, and M. S. Katz Epidermal growth factor upregulates beta -adrenergic receptor signaling in a human salivary cell line Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1164 - C1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lefrere, P. de Coppet, J.-C. Camelin, S. Le Lay, N. Mercier, N. Elshourbagy, A. Bril, I. Berrebi-Bertrand, B. Feve, and S. Krief Neuropeptide AF and FF Modulation of Adipocyte Metabolism. PRIMARY INSIGHTS FROM FUNCTIONAL GENOMICS AND EFFECTS ON beta -ADRENERGIC RESPONSIVENESS J. Biol. Chem., October 11, 2002; 277(42): 39169 - 39178. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bronnikov, T. Bengtsson, L. Kramarova, V. Golozoubova, B. Cannon, and J. Nedergaard {beta}1 to {beta}3 Switch in Control of Cyclic Adenosine Monophosphate during Brown Adipocyte Development Explains Distinct {beta}-Adrenoceptor Subtype Mediation of Proliferation and Differentiation Endocrinology, September 1, 1999; 140(9): 4185 - 4197. [Abstract] [Full Text] |
||||
![]() |
M. R. Candelore, L. Deng, L. Tota, X.-M. Guan, A. Amend, Y. Liu, R. Newbold, M. A. Cascieri, and A. E. Weber Potent and Selective Human beta 3-Adrenergic Receptor Antagonists J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 649 - 655. [Abstract] [Full Text] |
||||
![]() |
Z. Li, V. A. Vaidya, J. D. Alvaro, P. A. Iredale, R. Hsu, G. Hoffman, L. Fitzgerald, P. K. Curran, C. A. Machida, P. H. Fishman, et al. Protein Kinase C-Mediated Down-Regulation of beta 1-Adrenergic Receptor Gene Expression in Rat C6 Glioma Cells Mol. Pharmacol., July 1, 1998; 54(1): 14 - 21. [Abstract] [Full Text] |
||||
![]() |
D. E. Berkowitz, D. Brown, K. M. Lee, C. Emala, D. Palmer, Y. An, and M. Breslow Endotoxin-induced alteration in the expression of leptin and beta 3-adrenergic receptor in adipose tissue Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E992 - E997. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Martin, S. B. Kertesy, and G. R. Dubyak Down-Regulation of P2U-Purinergic Nucleotide Receptor Messenger RNA Expression During In Vitro Differentiation of Human Myeloid Leukocytes by Phorbol Esters or Inflammatory Activators Mol. Pharmacol., January 1, 1997; 51(1): 97 - 108. [Abstract] [Full Text] |
||||
![]() |
T. Bengtsson, K. Redegren, A. D. Strosberg, J. Nedergaard, and B. Cannon Down-regulation of beta 3 Adrenoreceptor Gene Expression in Brown Fat Cells Is Transient and Recovery Is Dependent upon a Short-lived Protein Factor J. Biol. Chem., December 27, 1996; 271(52): 33366 - 33375. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |